Superiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Ventilation Alone
Launched by RHODE ISLAND HOSPITAL · Feb 7, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the Adult Sotair® to see if it can improve breathing support during surgery compared to traditional manual ventilation. The trial will involve two groups of participants, where one group will use the Sotair® device attached to a manual breathing bag, while the other group will use manual ventilation alone. Researchers want to find out if using the Sotair® device provides better and safer breathing support for patients undergoing non-emergency surgeries with general anesthesia.
To be eligible for this trial, participants should be adults aged 18 to 80 who are scheduled for non-emergency surgery and are in good health (classified as Physical Status 1 or 2 by the American Society of Anesthesiologists). Those with certain health issues, particularly serious respiratory problems or facial conditions, will not be able to participate. If you join the study, you'll have the chance to help researchers understand how this new device can enhance patient care during surgery, while being monitored closely to ensure your safety throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients who are scheduled for non-emergency surgery with general anesthesia (w/artificial airway) at Rhode Island Hospital.
- • American Society Of Anesthesiologists Physical Status 1 and 2
- Exclusion Criteria:
- • American Society of Anesthesiologists Physical Status \>3 (e.g. respiratory disease)
- • Oropharyngeal or facial pathology
About Rhode Island Hospital
Rhode Island Hospital, a leading academic medical center and a key component of the Lifespan health system, is committed to advancing medical research and improving patient care through innovative clinical trials. As a principal teaching hospital for The Warren Alpert Medical School of Brown University, it integrates cutting-edge research with high-quality clinical services. The hospital's extensive clinical trial program spans various fields, including oncology, cardiology, neurology, and more, aiming to enhance treatment options and patient outcomes. By fostering collaboration among researchers, clinicians, and patients, Rhode Island Hospital plays a pivotal role in translating scientific discoveries into effective therapies and improving healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Patients applied
Trial Officials
Mark Kendall, MD
Principal Investigator
Rhode Island Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported